These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 2982643)
41. A comparison of the zinc contents and substrate specificities of the endothelial and testicular forms of porcine angiotensin converting enzyme and the preparation of isoenzyme-specific antisera. Williams TA; Barnes K; Kenny AJ; Turner AJ; Hooper NM Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):875-81. PubMed ID: 1335236 [TBL] [Abstract][Full Text] [Related]
42. Purification and characterisation of swine serum proteinase which hydrolyses epidermal inhibitory pentapeptide. Bramucci M; Miano A; Quassinti L; Maccari E; Canofeni S; Amici D Biochim Biophys Acta; 1996 Jun; 1290(2):184-90. PubMed ID: 8645722 [TBL] [Abstract][Full Text] [Related]
43. Preferred solution conformation of des-Arg9-bradykinin and analysis of structure-conformation-activity relationships in the series [Alan]des-Arg9-bradykinin. Dive V; Lintner K; Fermandjian S; St Pierre S; Regoli D Eur J Biochem; 1982 Mar; 123(1):179-90. PubMed ID: 7067697 [TBL] [Abstract][Full Text] [Related]
44. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P. Ward PE; Chow A; Drapeau G Biochem Pharmacol; 1991 Jul; 42(4):721-7. PubMed ID: 1651078 [TBL] [Abstract][Full Text] [Related]
46. Characterization of rat pulmonary vascular aminopeptidase P in vivo: role in the inactivation of bradykinin. Ryan JW; Berryer P; Chung AY; Sheffy DH J Pharmacol Exp Ther; 1994 Jun; 269(3):941-7. PubMed ID: 8014881 [TBL] [Abstract][Full Text] [Related]
47. Novel activity of human angiotensin I converting enzyme: release of the NH2- and COOH-terminal tripeptides from the luteinizing hormone-releasing hormone. Skidgel RA; Erdös EG Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1025-9. PubMed ID: 2983326 [TBL] [Abstract][Full Text] [Related]
49. Metabolism of neuropeptides. Hydrolysis of the angiotensins, bradykinin, substance P and oxytocin by pig kidney microvillar membranes. Stephenson SL; Kenny AJ Biochem J; 1987 Jan; 241(1):237-47. PubMed ID: 2436610 [TBL] [Abstract][Full Text] [Related]
50. Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice. Campbell DJ; Alexiou T; Xiao HD; Fuchs S; McKinley MJ; Corvol P; Bernstein KE Hypertension; 2004 Apr; 43(4):854-9. PubMed ID: 14769811 [TBL] [Abstract][Full Text] [Related]
51. Inhibition of angiotensin converting enzyme and potentiation of bradykinin by retro-inverso analogues of short peptides and sequences related to angiotensin I and bradykinin. Carmona AK; Juliano L Biochem Pharmacol; 1996 Apr; 51(8):1051-60. PubMed ID: 8866827 [TBL] [Abstract][Full Text] [Related]
52. Bradykinin is not involved in angiotensin converting enzyme modulation of ovarian steroidogenesis and prostaglandin production in frog Rana esculenta. Bramucci M; Miano A; Gobbetti A; Zerani M; Quassinti L; Maccari E; Murri O; Amici D Acta Physiol Scand; 2002 Jun; 175(2):123-8. PubMed ID: 12028132 [TBL] [Abstract][Full Text] [Related]
53. Potent inhibition of angiotensin-converting enzyme by [des-Pro3]-bradykinin or "converstatin" in comparison with Captopril. Okuda M; Arakawa K J Biochem; 1985 Sep; 98(3):621-8. PubMed ID: 3003038 [TBL] [Abstract][Full Text] [Related]
54. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. Vickers C; Hales P; Kaushik V; Dick L; Gavin J; Tang J; Godbout K; Parsons T; Baronas E; Hsieh F; Acton S; Patane M; Nichols A; Tummino P J Biol Chem; 2002 Apr; 277(17):14838-43. PubMed ID: 11815627 [TBL] [Abstract][Full Text] [Related]
55. The kinin B1 receptor antagonist des-Arg9-[Leu8]bradykinin: an antagonist of the angiotensin AT1 receptor which also binds to the AT2 receptor. Pruneau D; Duvoid A; Luccarini JM; Bélichard P; Bonnafous JC Br J Pharmacol; 1995 Jan; 114(1):115-8. PubMed ID: 7712006 [TBL] [Abstract][Full Text] [Related]
57. Isolation of brain endopeptidases: influence of size and sequence of substrates structurally related to bradykinin. Oliveira EB; Martins AR; Camargo AC Biochemistry; 1976 May; 15(9):1967-74. PubMed ID: 5120 [TBL] [Abstract][Full Text] [Related]
58. D-Phe7-substituted peptide bradykinin antagonists are not substrates for kininase II. Togo J; Burch RM; DeHaas CJ; Connor JR; Steranka LR Peptides; 1989; 10(1):109-12. PubMed ID: 2546127 [TBL] [Abstract][Full Text] [Related]
59. Selective inhibition of the C-domain of angiotensin I converting enzyme by bradykinin potentiating peptides. Cotton J; Hayashi MA; Cuniasse P; Vazeux G; Ianzer D; De Camargo AC; Dive V Biochemistry; 2002 May; 41(19):6065-71. PubMed ID: 11994001 [TBL] [Abstract][Full Text] [Related]
60. The enzymatic degradation of bradykinin in semen of various species. Heder G; Bøttger A; Siems WE; Rottmann M; Kertscher U Andrologia; 1994; 26(5):295-301. PubMed ID: 7825745 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]